Azenta AZTA
NASDAQ AZTA
$39.16 +1.78 (+4.76%)
At close: Nov 6, 2026 · 4:00 PM EST

Azenta (AZTA) Gains (Losses) on Sale of Assets & Investments (2011 - 2016)

Updated

Azenta's Non Operating Investment Income was $1.85 million in FY2017 (year ended Sep 30, 2017).

Analysis

Azenta (AZTA) Gains (Losses) on Sale of Assets & Investments (2011 - 2016) Analysis & Trends

  • The FY2017 figure marks the highest annual Non Operating Investment Income since FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Thermo Fisher Scientific 257.79 Bn 234.30 Bn 5.13 Bn -
2 Abbott Laboratories 190.83 Bn 164.70 Bn 7.39 Bn -
3 Danaher 162.10 Bn 141.75 Bn 3.84 Bn -
4 Intuitive Surgical 158.05 Bn 138.34 Bn 2.08 Bn -
5 Medtronic 130.31 Bn 95.56 Bn 6.34 Bn -
6 Stryker 124.76 Bn 110.95 Bn 4.25 Bn -
7 Boston Scientific 62.03 Bn 57.46 Bn 3.43 Bn -
8 Edwards Lifesciences 58.73 Bn 41.94 Bn 1.35 Bn -
9 Becton Dickinson 58.33 Bn 55.48 Bn 2.32 Bn -
10 Azenta 1.77 Bn 314.25 Mn 72.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 1.85 Mn
Jun 30, 2011 45.00 Mn
API Access

Azenta Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=AZTA&period=max&api_key=YOUR_API_KEY